ResearcherShanghai Jiao Tong UniversityNo recent work listed

Wei Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-0913-6355; OpenAlex author ID A5100432025. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 15

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 2 papers

Papers 3

SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. Co-author DOI 10.1038/s41418-021-00821-z ↗
MicroRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1. Co-author PMID 34761629 ↗
DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2019/8656282 ↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiao Tan · 1 shared paper, 2021 · strength 0.17
- Paper MicroRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1. PMID 34761629 ↗
Bole Tian · 1 shared paper, 2021 · strength 0.17
- Paper MicroRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1. PMID 34761629 ↗
Yan Wang · 1 shared paper, 2021 · strength 0.12
- Paper SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. DOI 10.1038/s41418-021-00821-z ↗
Shuai Leng · 1 shared paper, 2021 · strength 0.12
- Paper SIRT1 coordinates with the CRL4B complex to regulate pancreatic cancer stem cells to promote tumorigenesis. DOI 10.1038/s41418-021-00821-z ↗
Ruizhe He · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Jian‐Yu Yang · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Zhigang Zhang · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Xueliang Fu · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Yongwei Sun · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Dejun Liu · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Junfeng Zhang · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Minwei Yang · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Rong Hua · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Yongsheng Jiang · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗
Yan‐Miao Huo · 1 shared paper, 2019 · strength 0.08
- Paper DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1155/2019/8656282 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.